About Careers Internship MedBlog Contact us

US President Trump Signs Bipartisan Bill to Fight Drug Trafficking

by Thilaka Ravi on January 11, 2018 at 3:42 PM
US President Trump Signs Bipartisan Bill to Fight Drug Trafficking

US President Donald Trump has signed a legislation that aims to stop the flow of illegal drugs into the United States. The bill grants $9 million to the Customs and Border Protection to fight trafficking of opioid analgesics, entering the US from Mexico and Canada.

The initiative is specifically aimed at ending the trafficking of fentanyl, a white powder analgesic 30-50 times more powerful than heroin and usually used to treat cancer, although in recent years, criminal groups have used it to increase the potency of heroin.


The drug traffickers "are using our postal system and they're killing our people," Trump said on Wednesday while signing the bill in the Oval Office, accompanied by Vice President, Mike Pence, and 17 legislators from both parties, Efe news reported.

According to the US Drug Enforcement Administration (DEA), fentanyl is manufactured in China but enters US territory across the borders with Mexico and Canada, where the drug arrives by postal mail and in very small quantities, making it very difficult to detect.

Trump said that the new bill is "a significant step forward" in the fight against fentanyl, a substance which, according to him, is so dangerous that it has killed police sniffing dogs.

"Even dogs die from the scent," Trump said, adding that "nobody has ever seen anything like this."

The law that Trump signed on Wednesday stipulates that the US Customs and Border Protection (CBP) must have portable chemical screening devices at ports of entry and at mail facilities.

Specifically, the legislation grants $9 million to the CBP to purchase hundreds of such devices as well as laboratory equipment.

The bill was passed in the House of Representatives with 412 votes in favour and only 3 against, and it subsequently received the unanimous support from the Senate.

Over the past six years, drug overdose deaths have become the most common cause of violent death in the US, over and above road traffic accidents or weapons.

According to data from the Centers for Disease Control and Prevention (CDC), 64,000 Americans died from drug overdoses in 2016.

Fentanyl is directly linked to more than 700 deaths between the end of 2013 and the beginning of 2015, according to the latest data from the DEA.

Source: IANS
Font : A-A+



Recommended Readings

Latest Alcohol & Drug Abuse News

US Drug Overdose Deaths Quadruple from 1999 to 2020
The United States is currently witnessing its highest overall mortality rates in over a century, driven in part by the surge in drug overdose fatalities.
Genes Linked to Psychostimulant Drug Addiction Identified
Deciphering genetic factors in brain responses to METH and COC enables personalized approaches to combat drug abuse.
Insomnia Drug DORA-12 Shows Promise in Preventing Oxycodone Relapse
Giving rats DORA-12 during oxycodone withdrawal reduced future drug-seeking behavior, showing promise for preventing opioid addiction and relapse in humans.
France is All Set to Put a 'Full Stop' to Disposable Vapes
Rising to 9.6% in 2021, daily vaping among New Zealand's 14-year-old students underscores a concerning youth trend.
Rising Marijuana Use Linked to Higher Blood and Urine Toxic Metal Levels
The research also revealed a 22 percent increase in cadmium levels among marijuana users.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

US President Trump Signs Bipartisan Bill to Fight Drug Trafficking Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests